Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endothelial cell cytoskeleton within tumor vasculature is a network of protein filaments (actin filaments, microtubules, and intermediate filaments) crucial for maintaining vessel integrity, regulating permeability, and enabling angiogenesis. Its unique features and regulatory mechanisms are potential therapeutic targets for disrupting abnormal vessel formation, reducing nutrient supply to tumors, enhancing drug delivery, and limiting metastasis. Key regulators include growth factors (VEGF), adhesion molecules (VE-cadherin), Rho GTPases, and the Notch pathway.
Disruption of tumor blood supply by targeting cytoskeletal components or regulators, inhibiting angiogenesis and normalizing aberrant vasculature.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Vasculature (Endothelial Cell Cytoskeleton).